ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Cardiovascular Endocrinology
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1665292
The triglyceride-glucose index is associated with coronary plaque features and clinical outcomes in patients with ST-segment elevation myocardial infarction
Provisionally accepted- 1The Second Affiliated Hospital of Harbin Medical University, Harbin, China
- 2State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin Medical University, Harbin, China
- 3The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: The triglyceride-glucose (TyG) index is a reliable surrogate marker for insulin resistance, and is associated with cardiovascular diseases. However, the specific impact of TyG index on coronary plaque vulnerability and long-term outcomes in patients with ST-segment elevation myocardial infarction (STEMI) has not been fully investigated. This study aimed to investigate the association of the TyG index with coronary plaque characteristics and clinical outcomes. Methods: Between January 2017 to December 2019, 1,831 STEMI patients who underwent optical coherence tomography imaging were retrospectively enrolled. Patients were divided into three groups based on TyG index tertiles (Group T1: <8.82, Group T2: 8.82-9.41, Group T3: ≥9.41). Major adverse cardiovascular and cerebrovascular events (MACCE) included cardiac death, non-fatal stroke, non-fatal myocardial infarction, ischemia-driven revascularization, and rehospitalization. Results: The average age was 58.7 years, and 72.1% were male. The incidence of plaque rupture, thin-cap fibroatheromas, macrophages, and the size of lipid core, increased with increasing TyG index tertiles (all P<0.05). Multivariate logistic regression analysis showed that TyG index independently predicted culprit plaque rupture (T2: OR 1.39, 95%CI 1.06-1.82; T3: OR 1.51, 95%CI 1.05-2.16; T1 as reference). During a median follow-up of 4.2 years, 541 (29.9%) patients developed MACCE. Patients in the highest TyG index tertile had a significantly higher cumulative incidence of MACCE (43.5% vs. 37.3% vs. 31.1%, P=0.007) than the other two groups. After adjusting for clinical risk factors and coronary plaque features, the increased TyG index independently predicted MACCE (HR 1.18, 95%CI 1.00-1.38, per unit increased). This association was notable in patients without diabetes but was not demonstrable in diabetes (interaction P-value <0.05). Conclusions: In patients with STEMI, elevated TyG index increased atherosclerotic plaque vulnerability, and independently predicted plaque rupture. A higher TyG index was an independent predictor of MACCE, especially for patients without diabetes.
Keywords: Major adverse cardiovascular and cerebrovascular events, Optical Coherence Tomography, Plaque vulnerability, ST-segment elevation myocardial infarction, Triglyceride-glucose index
Received: 14 Jul 2025; Accepted: 02 Sep 2025.
Copyright: © 2025 Guo, Cui, Guo, Jin, Xiu, Gao, Zhao, Xu, Tan, Han, Li, Chen, Dai, Yu and Fang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Bo Yu, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.